Nov 01, 2020
Immutep’s TACTI-002 Data To Be Presented At Society For Immunotherapy Of Cancer 2020 Annual Meeting
Oct 29, 2020
Immutep to Collaborate with LabCorp to Develop Oncology Services and Products
Oct 22, 2020
Immutep Announces the Start of an Investigator-Initiated Phase II Study in COVID-19 Patients
Oct 21, 2020
Immutep Granted European Patent for IMP761
Immutep Activities Report for the First Quarter of Fiscal Year 2021
